Cancer stem cells: a model in the making

Current Opinion in Genetics and Development

Volumn 19, Issue 1, 2009, Pages 44-50

  Marotta, Lauren L Campbell ^a   Polyak, Kornelia ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CELL; CANCER RECURRENCE; CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL HETEROGENEITY; CELL MATURATION; CELL TYPE; EPITHELIUM; HUMAN; MESENCHYME; METASTASIS; MOLECULAR MODEL; PRIMARY TUMOR; PRIORITY JOURNAL; REVIEW; TUMOR GROWTH;

ANIMALS; HUMANS; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; NEOPLASTIC STEM CELLS;

EID: 60949084535     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gde.2008.12.003     Document Type: Review

References (53)

1. Fialkow P.J. Clonal origin of human tumors. Annu Rev Med 30 (1979) 135-143
2. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
3. Vogelstein B., and Kinzler K.W. Cancer genes and the pathways they control. Nat Med 10 (2004) 789-799
4. Nowell P.C. The clonal evolution of tumor cell populations. Science 194 (1976) 23-28
5. Pierce G.B. Neoplastic stem cells. Adv Pathobiol 6 (1977) 141-152
6. Wicha M.S., Liu S., and Dontu G. Cancer stem cells: an old idea - a paradigm shift. Cancer Res 66 (2006) 1883-1890
7. Cohnheim J. Congenitales, quergestreiftes Muskelsarkom der Nieren. Virchows Arch Patholo Anat Physiol Klin Med 65 (1875) 64-69
8. Lapidot T., Sirard C., Vormoor J., Murdoch B., Hoang T., Caceres-Cortes J., Minden M., Paterson B., Caligiuri M.A., and Dick J.E. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367 (1994) 645-648
9. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., and Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100 (2003) 3983-3988
10. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., and Dirks P.B. Identification of a cancer stem cell in human brain tumors. Cancer Res 63 (2003) 5821-5828
11. + prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 25 (2006) 1696-1708
12. Li C., Heidt D.G., Dalerba P., Burant C.F., Zhang L., Adsay V., Wicha M., Clarke M.F., and Simeone D.M. Identification of pancreatic cancer stem cells. Cancer Res 67 (2007) 1030-1037
13. Prince M.E., Sivanandan R., Kaczorowski A., Wolf G.T., Kaplan M.J., Dalerba P., Weissman I.L., Clarke M.F., and Ailles L.E. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A 104 (2007) 973-978
14. Ricci-Vitiani L., Lombardi D.G., Pilozzi E., Biffoni M., Todaro M., Peschle C., and De Maria R. Identification and expansion of human colon-cancer-initiating cells. Nature 445 (2007) 111-115
15. Eramo A., Lotti F., Sette G., Pilozzi E., Biffoni M., Di Virgilio A., Conticello C., Ruco L., Peschle C., and De Maria R. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 15 (2008) 504-514
16. Schatton T., Murphy G.F., Frank N.Y., Yamaura K., Waaga-Gasser A.M., Gasser M., Zhan Q., Jordan S., Duncan L.M., Weishaupt C., et al. Identification of cells initiating human melanomas. Nature 451 (2008) 345-349
17. Yang Z.F., Ngai P., Ho D.W., Yu W.C., Ng M.N.P., Lau C.K., Li M.L.Y., Tam K.H., Lam C.T., Poon R.T.P., and Fan S.T. Identification of local and circulating cancer stem cells in human liver cancer. Hepatology 47 (2008) 919-928
18. Zhang S., Balch C., Chan M.W., Lai H.C., Matei D., Schilder J.M., Yan P.S., Huang T.H.M., and Nephew K.P. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res 68 (2008) 4311-4320. In this paper, the authors find cancer stem cells in tumors from the ovary, the most recent tissue type from which such cells have been isolated.
19. Hombach-Klonisch S., Panigrahi S., Rashedi I., Seifert A., Alberti E., Pocar P., Kurpisz M., Schulze-Osthoff K., Mackiewicz A., and Los M. Adult stem cells and their trans-differentiation potential - perspectives and therapeutic applications. J Mol Med 86 (2008) 1301-1314
20. Mizrak D., Brittan M., and Alison M.R. CD133: molecule of the moment. J Pathol 214 (2008) 3-9
21. Douville J., Beaulieu R., and Balicki D. ALDH1 as a functional marker of cancer stem and progenitor cells. Stem Cells Dev 18 (2009) 16-26
22. Bloushtain-Qimron N., Yao J., Snyder E.L., Shipitsin M., Campbell L.L., Mani S.A., Hu M., Chen H., Ustyansky V., Antosiewicz J.E., et al. Cell type-specific DNA methylation patterns in the human breast. Proc Natl Acad Sci U S A 105 (2008) 14076-14081
23. Shipitsin M., Campbell L.L., Argani P., Weremowicz S., Bloushtain-Qimron N., Yao J., Nikolskaya T., Serebryiskaya T., Beroukhim R., Hu M., et al. Molecular definition of breast tumor heterogeneity. Cancer Cell 11 (2007) 259-273. The authors of this paper analyze the global gene expression profiles of putative breast cancer stem cells, more differentiated cancer cells, and their normal counterparts.
24. Klonisch T., Wiechec E., Hombach-Klonisch S., Ande S.R., Wesselborg S., Schulze-Osthoff K., and Los M. Cancer stem cell markers in common cancers - therapeutic implications. Trends Mol Med 14 (2008) 450-460
25. Cho R.W., and Clarke M.F. Recent advances in cancer stem cells. Curr Opin Genet Dev 18 (2008) 48-53
26. Polyak K., and Hahn W.C. Roots and stems: stem cells in cancer. Nat Med 12 (2006) 296-300
27. Hill R.P. Identifying cancer stem cells in solid tumors: case not proven. Cancer Res 66 (2006) 1891-1895
28. Kelly P.N., Dakic A., Adams J.M., Nutt S.L., and Strasser A. Tumor growth need not be driven by rare cancer stem cells. Science 317 (2007) 337
29. Vermeulen L., Sprick M.R., Kemper K., Stassi G., and Medema J.P. Cancer stem cells - old concepts, new insights. Cell Death Differ 15 (2008) 947-958
30. Campbell L.L., and Polyak K. Breast tumor heterogeneity: cancer stem cells or clonal evolution?. Cell Cycle 6 (2007) 2332-2338. This perspective compares and contrasts the cancer stem cells hypothesis with the long-standing clonal evolution model and explains how the first can be considered an extension of the second using breast cancer as an example.
31. Visvader J.E., and Lindeman G.J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8 (2008) 755-768. This extensive review lists most of the markers used to purify cancer stem cells from primary tumors and also discusses many experiments demonstrating the sensitivity and resistance of cancer stem cells to various chemotherapeutic agents.
32. Merlo L.M.F., Pepper J.W., Reid B.J., and Maley C.C. Cancer as an evolutionary and ecological process. Nat Rev Cancer 6 (2006) 924-935
33. Zeppernick F., Ahmadi R., Campos B., Dictus C., Helmke B.M., Becker N., Lichter P., Unterberg A., Radlwimmer B., and Herold-Mende C.C. Stem cell marker CD133 affects clinical outcome in glioma patients. Clin Cancer Res 14 (2008) 123-129
34. Mani S.A., Guo W., Liao M.J., Eaton E.N., Ayyanan A., Zhou A.Y., Brooks M., Reinhard F., Zhang C.C., Shipitsin M., et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133 (2008) 704-715
35. Hermann P.C., Huber S.L., Herrler T., Aicher A., Ellwart J.W., Guba M., Bruns C.J., and Heeschen C. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1 (2007) 313-323. The authors of this study describe their interesting findings that a subset of pancreatic cancer stem cells found at the invasive edge of tumors are responsible for metastasis but not for tumorigenicity of the overall cancer stem cell population.
36. + cells with cancer stem cell characteristics. Breast Cancer Res 10 (2008) R10
37. Ailles L.E., and Weissman I.L. Cancer stem cells in solid tumors. Curr Opin Biotechnol 18 (2007) 460-466
38. Dylla S.J., Beviglia L., Park I.K., Chartier C., Raval J., Ngan L., Pickell K., Aguilar J., Lazetic S., Smith-Berdan S., et al. Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy. PLoS ONE 3 (2008) e2428
39. Bao S., Wu Q., McLendon R.E., Hao Y., Shi Q., Hjelmeland A.B., Dewhirst M.W., Bigner D.D., and Rich J.N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444 (2006) 756-760
40. + breast cancer-initiating cells to radiation. J Natl Cancer Inst 98 (2006) 1777-1785
41. Yu F., Yao H., Zhu P., Zhang X., Pan Q., Gong C., Huang Y., Hu X., Su F., Lieberman J., and Song E. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131 (2007) 1109-1123
42. Wicha M.S. Cancer stem cell heterogeneity in hereditary breast cancer. Breast Cancer Res 10 (2008) 105
43. Guzman M.L., Rossi R.M., Neelakantan S., Li X., Corbett C.A., Hassane D.C., Becker M.W., Bennett J.M., Sullivan E., Lachowicz J.L., et al. An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells. Blood 110 (2007) 4427-4435
44. Yilmaz O.H., and Morrison S.J. The PI-3kinase pathway in hematopoietic stem cells and leukemia-initiating cells: a mechanistic difference between normal and cancer stem cells. Blood Cells Mol Dis 41 (2008) 73-76
45. Beier D., Röhrl S., Pillai D.R., Schwarz S., Kunz-Schughart L.A., Leukel P., Proescholdt M., Brawanski A., Bogdahn U., Trampe-Kieslich A., et al. Temozolomide preferentially depletes cancer stem cells in glioblastoma. Cancer Res 68 (2008) 5706-5715
46. Calabrese C., Poppleton H., Kocak M., Hogg T.L., Fuller C., Hamner B., Oh E.Y., Gaber M.W., Finklestein D., Allen M., et al. A perivascular niche for brain tumor stem cells. Cancer Cell 11 (2007) 69-82
47. Ito K., Bernardi R., Morotti A., Matsuoka S., Saglio G., Ikeda Y., Rosenblatt J., Avigan D.E., Teruya-Feldstein J., and Pandolfi P.P. PML targeting eradicates quiescent leukaemia-initiating cells. Nature 453 (2008) 1072-1078
48. Malanchi I., Peinado H., Kassen D., Hussenet T., Metzger D., Chambon P., Huber M., Hohl D., Cano A., Birchmeier W., and Huelsken J. Cutaneous cancer stem cell maintenance is dependent on β-catenin signalling. Nature 452 (2008) 650-653
49. Li X., Lewis M.T., Huang J., Gutierrez C., Osborne C.K., Wu M.F., Hilsenbeck S.G., Pavlick A., Zhang X., Chamness G.C., et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst 100 (2008) 672-679. This article reports the effects of chemotherapy and lapatinib on the percentage of cells with the breast cancer stem cell phenotype in patients.
50. Adams J.M., and Strasser A. Is tumor growth sustained by rare cancer stem cells or dominant clones?. Cancer Res 68 (2008) 4018-4021
51. Shipitsin M., and Polyak K. The cancer stem cell hypothesis: in search of definitions, markers, and relevance. Lab Invest 88 (2008) 459-463
52. Bates J: Cancer Stem Cells: Emerging Therapeutic, Diagnostic and Market Opportunities. BioPharm Reports; 2008.
53. Quintana E., Shackleton M., Sabel M.S., Fullen D.R., Johnson T.M., and Morrison S.J. Efficient tumour formation by single human melanoma cells. Nature 456 (2008) 593-599